Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Cell Competition in Development and Disease (2019B6)
Regenerative Biology and Applications: Cell Differentiation, Tissue Organization and Biomedical Engineering (2018T3)

Web Desc
iPSCs: A Decade of Progress and Beyond Organizer(s): Shinya Yamanaka, Haruhisa Inoue and Yanhong Shi Date: March 25 - 29, 2018 Location: Resort at Squaw Creek, Olympic Valley, CA, USA Sponsored by California Institute for Regenerative Medicine (CIRM) and Cell Research For important information on the coronavirus, please click here Summary of Meeting: The breakthrough discovery of iPSCs has transformed our prospects for regenerative medicine. The use of disease-specific iPSCs provides great hope for developing surrogate models of human diseases, platforms for drug discovery, and stem cell-based cell replacement therapies. Cutting-edge iPSC technologies, including small molecule-induced reprogramming, efficient lineage-specific differentiation, targeted gene editing, and comprehensive disease modeling will be highlighted in this symposium. The overall goals are to: 1) Promote a further understanding of the application of iPSC technology to model human diseases and develop new therapies; 2) Facilitate the integration of the iPSC technology with emerging technologies, such as CRISPR/Cas9 gene editing technology; 3) Stimulate the development of new technologies; and 4) Promote collaborations among the scientists attending. In a year when the Nobel prize-winning iPSC technology reaches its 10th anniversary, the prospect of using iPSC technology to observe the development of human diseases in a dish and to develop cell replacement therapies is truly tantalizing. However, the iPSC technology is still facing many challenges. This symposium will present the most recent advances in this rapidly evolving research area to address the needs of the field. Due to the enormous potential of the iPSC technology in disease modeling, drug discovery and therapeutic development, this symposium will appeal to a wide community of researchers and clinicians alike. Scholarship Deadline: November 30 2017 Discounted Abstract Deadline: December 1 2017 Abstract Deadline: December 21 2017 Discounted Registration Deadline: January 18 2018 Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested. Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support from these exhibitors at this conference: We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: Thermo Fisher Scientific Inc. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

iPSCs: A Decade of Progress and Beyond

Organizer(s): Shinya Yamanaka, Haruhisa Inoue and Yanhong Shi

Date: March 25 - 29, 2018
Location: Resort at Squaw Creek, Olympic Valley, CA, USA

Sponsored by California Institute for Regenerative Medicine (CIRM) and Cell Research

For important information on the coronavirus, please click here

Summary of Meeting:

The breakthrough discovery of iPSCs has transformed our prospects for regenerative medicine. The use of disease-specific iPSCs provides great hope for developing surrogate models of human diseases, platforms for drug discovery, and stem cell-based cell replacement therapies. Cutting-edge iPSC technologies, including small molecule-induced reprogramming, efficient lineage-specific differentiation, targeted gene editing, and comprehensive disease modeling will be highlighted in this symposium. The overall goals are to: 1) Promote a further understanding of the application of iPSC technology to model human diseases and develop new therapies; 2) Facilitate the integration of the iPSC technology with emerging technologies, such as CRISPR/Cas9 gene editing technology; 3) Stimulate the development of new technologies; and 4) Promote collaborations among the scientists attending. In a year when the Nobel prize-winning iPSC technology reaches its 10th anniversary, the prospect of using iPSC technology to observe the development of human diseases in a dish and to develop cell replacement therapies is truly tantalizing. However, the iPSC technology is still facing many challenges. This symposium will present the most recent advances in this rapidly evolving research area to address the needs of the field. Due to the enormous potential of the iPSC technology in disease modeling, drug discovery and therapeutic development, this symposium will appeal to a wide community of researchers and clinicians alike.

Scholarship Deadline: November 30 2017

Discounted Abstract Deadline: December 1 2017

Abstract Deadline: December 21 2017

Discounted Registration Deadline: January 18 2018

Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support from these exhibitors at this conference:

We gratefully acknowledge additional support for this conference from:

March of Dimes Foundation, Grant No. 4-FY18-826

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Thermo Fisher Scientific Inc.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program


Sunday, March 25 \| 4:00PM - 8:00PM Arrival and Registration Room: Lobby Alcove
Sunday, March 25 \| 6:00PM - 8:00PM Welcome Mixer Room: Cascades No registration fees are used to fund alcohol served at this function.
Monday, March 26 \| 7:00AM - 8:00AM Breakfast Room: Cascades
Monday, March 26 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Grand Sierra Ballroom A-B Speaker 1 of 3 * Haruhisa Inoue, Center for iPS Cell Research and Application, Kyoto University, RIKEN, Japan
Monday, March 26 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Grand Sierra Ballroom A-B Speaker 2 of 3 * Yanhong Shi, Beckman Research Institute of City of Hope, USA
Monday, March 26 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Grand Sierra Ballroom A-B Speaker 3 of 3 * Shinya Yamanaka, Gladstone Institute of Cardiovascular Disease, USA, Center for iPS Cell Research and Application, Kyoto University, Japan, Japan iPSC Technology-The Past, Present and Future
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Speaker 1 of 7 * Shinya Yamanaka, Gladstone Institute of Cardiovascular Disease, USA, Center for iPS Cell Research and Application, Kyoto University, Japan, Japan
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Speaker 2 of 7 Fred H. Gage, The Salk Institute for Biological Studies, USA Applications of iPS Cells to Reveal Insights into Biological Psychiatry
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Coffee Break
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Speaker 4 of 7 Rudolf Jaenisch, Whitehead Institute for Biomedical Research, USA Stem Cells and Epigenetic Regulation in Development and Disease
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Speaker 5 of 7 Yanhong Shi, Beckman Research Institute of City of Hope, USA Modeling Neurological Diseases Using Patient iPSCs
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Speaker 6 of 7 Ji Hyeon Ju, Catholic University of Korea, South Korea Short Talk: Disease Modeling using Induced Pluripotent Stem Cells of Patients with Systemic Sclerosis
Monday, March 26 \| 9:00AM - 11:30AM iPSC-Based Disease Modeling Room: Grand Sierra Ballroom A-B Speaker 7 of 7 Aparna Venkatesh, Agency for Science and Technology Singapore, Singapore Short Talk: Advances in Down Syndrome Disease Modeling Using hiPSC
Monday, March 26 \| 11:30AM - 11:45AM Overview of CIRM's Programs/Funding Opportunities Room: Grand Sierra Ballroom A-B Speaker 1 of 1 * Kelly A. Shepard, California Institute for Regenerative Medicine, USA
Monday, March 26 \| 11:45AM - 5:00PM On Own for Lunch
Monday, March 26 \| 11:45AM - 1:00PM Poster Setup Room: Alpine Ballroom
Monday, March 26 \| 1:00PM - 10:00PM Poster Viewing Room: Alpine Ballroom
Monday, March 26 \| 4:30PM - 5:00PM Coffee Available Room: Sierra Prefunction
Monday, March 26 \| 5:00PM - 7:00PM Drug Discovery using iPSC Platforms Room: Grand Sierra Ballroom A-B Speaker 1 of 5 * Yanhong Shi, Beckman Research Institute of City of Hope, USA
Monday, March 26 \| 5:00PM - 7:00PM Drug Discovery using iPSC Platforms Room: Grand Sierra Ballroom A-B Speaker 2 of 5 Haruhisa Inoue, Center for iPS Cell Research and Application, Kyoto University, RIKEN, Japan Human Pluripotent Stem Cells in Neurological Drug Discovery
Monday, March 26 \| 5:00PM - 7:00PM Drug Discovery using iPSC Platforms Room: Grand Sierra Ballroom A-B Speaker 3 of 5 Ricardo E. Dolmetsch, Novartis Institutes for BioMedical Research, USA Using Stem Cell to Develop Drugs in Pediatric Neurology
Monday, March 26 \| 5:00PM - 7:00PM Drug Discovery using iPSC Platforms Room: Grand Sierra Ballroom A-B Speaker 4 of 5 David Piper, Thermo Fisher Scientific, USA Removing Inherent Bottlenecks in the Genome Engineering of iPSCs to Build Relevant Disease Models for Target and Compound Screening
Monday, March 26 \| 5:00PM - 7:00PM Drug Discovery using iPSC Platforms Room: Grand Sierra Ballroom A-B Speaker 5 of 5 Rik van der Kant, Vrije Universiteit, Netherlands Short Talk: A Drug Screen in iPSC-Alzheimer's Disease Neurons Identifies Cholesterol Metabolism as an Aß Independent Regulator of Tau Dysfunction
Monday, March 26 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Cascades No registration fees are used to fund alcohol served at this function.
Monday, March 26 \| 7:30PM - 10:00PM Poster Session 1 Room: Alpine Ballroom
Tuesday, March 27 \| 7:00AM - 8:00AM Breakfast Room: Cascades
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 1 of 8 * Haruhisa Inoue, Center for iPS Cell Research and Application, Kyoto University, RIKEN, Japan
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 2 of 8 Madeline Lancaster, Medical Research Council Laboratory of Molecular Biology, UK Studying Human Brain Development and Evolution in Cerebral Organoids
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 3 of 8 Guo-li Ming, University of Pennsylvania, USA Brain-Region-Specific Organoids for Modeling Neurodevelopment and Disease
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Coffee Break
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 5 of 8 Flora M. Vaccarino, Yale University School of Medicine, USA Integrative Multi-Omics Analyses of iPSC-Derived Brain Organoids Identify Early Determinants of Human Cortical Development
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 6 of 8 Hongjun Song, University of Pennsylvania, USA Epitranscriptomic Regulation in the Nervous System
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 7 of 8 Mark A. Skylar-Scott, Harvard University, USA Short Talk: Embedded 3D Bioprinting of Vascularized Organ-Specific Tissues at Scale
Tuesday, March 27 \| 8:00AM - 11:15AM 3D Modeling Using Organoids Room: Grand Sierra Ballroom A-B Speaker 8 of 8 Kapil Bharti, National Institutes of Health, USA Short Talk: Patient-Specific 3D Bioprinted Eye Tissue to Understand and Treat Macular Degeneration
Tuesday, March 27 \| 11:15AM - 5:00PM On Own for Lunch
Tuesday, March 27 \| 11:15AM - 1:00PM Poster Setup Room: Alpine Ballroom
Tuesday, March 27 \| 1:00PM - 10:00PM Poster Viewing Room: Alpine Ballroom
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 1 of 8 * Hongjun Song, University of Pennsylvania, USA
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 2 of 8 Narae Park, Catholic University of Korea, South Korea Autoimmune Disease Modeling in vitro with Combination of iPSC-Derived Cardiomyocytes and Disease-Active Serum
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 3 of 8 Ellis Kim, University of Chicago, USA iPSC-Derived Cardiomyocytes Highlight the Differences between Myotonic Dystrophy Subtypes
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 4 of 8 Masayuki Yazawa, Columbia University, USA Human iPSC-Based Screen for FDA Drug Repurposing to Rescue Severe Cardiac Arrhythmia
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 5 of 8 Yibing Qyang, Yale University, USA Human Tissue-Engineered Blood Vessels Derived from Induced Pluripotent Stem Cells
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 6 of 8 Ksenia Blinova, Food and Drug Administration, USA Human iPSC-Derived Myocytes for Preclinical Assessment of Drug-Induced Cardiac Toxicities
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 7 of 8 Alma Forsman, Biomedicine at Gothenburg University, Sweden Cartilage Mimics Generation by 3D Bioprinting of Induced Pluripotent Stem Cells in a Modified Bioink
Tuesday, March 27 \| 2:30PM - 4:30PM Workshop 1 Room: Grand Sierra Ballroom A-B Speaker 8 of 8 Ilyas Singec, National Institutes of Health, USA GMP-Compatible Robotic Cell Expansion, Combinatorial Small Molecule Screening, and Directed Differentiation of Human iPS Cells into Multiple Cells
Tuesday, March 27 \| 4:30PM - 5:00PM Coffee Available Room: Sierra Prefunction
Tuesday, March 27 \| 5:00PM - 7:00PM Gene Editing of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 1 of 5 * Fred H. Gage, The Salk Institute for Biological Studies, USA
Tuesday, March 27 \| 5:00PM - 7:00PM Gene Editing of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 2 of 5 Ru Gunawardane, Allen Institute for Cell Science, USA Systematic Gene Tagging with CRISPR/Cas9 to Illuminate Stem Cell Organization and Dynamics
Tuesday, March 27 \| 5:00PM - 7:00PM Gene Editing of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 3 of 5 Yadong Huang, Gladstone Institutes/UCSF, USA Alzheimer's Disease Modeling and Drug Screening Using Gene-Edited Human iPSCs
Tuesday, March 27 \| 5:00PM - 7:00PM Gene Editing of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 4 of 5 Alysson R. Muotri, University of California, San Diego, USA Applications of Brain-Model Technology
Tuesday, March 27 \| 5:00PM - 7:00PM Gene Editing of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 5 of 5 Kathleen Worringer, Novartis Institutes for BioMedical Research, USA Short Talk: CRISPR Screening in Human Pluripotent Stem Cells and Neurons
Tuesday, March 27 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Cascades No registration fees are used to fund alcohol served at this function.
Tuesday, March 27 \| 7:30PM - 10:00PM Poster Session 2 Room: Alpine Ballroom
Wednesday, March 28 \| 7:00AM - 8:00AM Breakfast Room: Cascades
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Speaker 1 of 7 * Ronald M. Evans, HHMI/The Salk Institute, USA
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Speaker 2 of 7 Juan Carlos Izpisua-Belmonte, The Salk Institute for Biological Studies, USA In vitro and in vivo Approaches for Cell and Tissue Generation
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Speaker 3 of 7 Hiromitsu Nakauchi, Stanford University, USA Interspecies Cell/Organogenesis: In vivo Generation of Functional Cells and Organs from iPS Cells
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Coffee Break
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Speaker 5 of 7 Deepak Srivastava, Gladstone Institutes, USA Cellular Reprogramming Approaches for Cardiovascular Disease
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Speaker 6 of 7 Peter Loskill, Fraunhofer Institute for Interfacial Engineering and Biotechnology, Germany Short Talk: Stem Cell-Based Microphysiological Organ-on-a-Chip Systems as in vitro Models of Human Tissue with Physiological Structure and Function
Wednesday, March 28 \| 8:00AM - 11:00AM Organ Generation from iPSCs Room: Grand Sierra Ballroom A-B Speaker 7 of 7 Vivian M. Lee, STEMCELL Technologies, Inc., Canada Short Talk: The STEMdiffTM Cerebral Organoid Kit Generates Organoids that Recapitulate Early Brain Development
Wednesday, March 28 \| 11:00AM - 5:00PM On Own for Lunch
Wednesday, March 28 \| 11:00AM - 1:00PM Poster Setup Room: Alpine Ballroom
Wednesday, March 28 \| 1:00PM - 10:00PM Poster Viewing Room: Alpine Ballroom
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 1 of 9 * Guo-li Ming, University of Pennsylvania, USA
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 2 of 9 Masashi Miyauchi, Graduate School of Medicine, University of Tokyo, Japan Patient-Derived Induced Pluripotent Stem Cells Identify ADAM8 as an Antigen of TKI-Resistant Chronic Myeloid Leukemia Cells
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 3 of 9 David F. Fischer, Charles River, UK Use of Pluripotent Stem Cells and Stem Cells-Derived Neurons in Support of Drug Discovery and Target Validation
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 4 of 9 Michela Deleidi, German Center for Neurodegenerative Diseases, Germany Enhancing Mitochondrial Biogenesis via NAD+ Precursors Rescues Mitochondrial Function and Neurodegeneration in iPSC and Fly Models of Parkinson's Disease
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 5 of 9 Chunli Zhao, Stanford University, USA Defining the Pathogenesis of Undiagnosed Diseases Using iPSC
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 6 of 9 Paul George, Stanford University, USA Engineered Cerebral Cortex-like Conductive Scaffold Generates Functional Neurons
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 7 of 9 Zachary Pappalardo, Xcell Biosciences, USA Application of Atmospheric Pressure and Hypoxia during Culture Promotes Neural Induction of iPSCs and Subsequent Differentiation into Adult Neurons
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 8 of 9 Taewan Kim, Memorial Sloan Kettering Cancer Center, USA Derivation of Enriched Engraftable Midbrain Dopamine Neurons from hPSC in a cGMP-Qualified Condition
Wednesday, March 28 \| 2:30PM - 4:30PM Workshop 2 Room: Grand Sierra Ballroom A-B Speaker 9 of 9 Karen Litwa, East Carolina University, USA Cytoskeletal Regulation of Neurodevelopment in an hIPSC-Derived Autism Model
Wednesday, March 28 \| 4:30PM - 5:00PM Coffee Available Room: Sierra Prefunction
Wednesday, March 28 \| 5:00PM - 7:00PM Stem Cell Therapeutic Development Room: Grand Sierra Ballroom A-B Speaker 1 of 5 * Deepak Srivastava, Gladstone Institutes, USA
Wednesday, March 28 \| 5:00PM - 7:00PM Stem Cell Therapeutic Development Room: Grand Sierra Ballroom A-B Speaker 2 of 5 Ronald M. Evans, HHMI/The Salk Institute, USA Therapeutic Development for Diabetes Using Personalized Insulin-Producing Cells
Wednesday, March 28 \| 5:00PM - 7:00PM Stem Cell Therapeutic Development Room: Grand Sierra Ballroom A-B Speaker 3 of 5 Ole Isacson, Harvard Medical School/McLean Hospital, USA Functional Connectivity from iPSC-Derived Dopamine Neurons and the Use of Primate Models of Parkinson’s Disease
Wednesday, March 28 \| 5:00PM - 7:00PM Stem Cell Therapeutic Development Room: Grand Sierra Ballroom A-B Speaker 4 of 5 Christine L. Mummery, Leiden University Medical Center, Netherlands Cardiovascular Diseases and Drugs: Where Are We with hiPSC Models?
Wednesday, March 28 \| 5:00PM - 7:00PM Stem Cell Therapeutic Development Room: Grand Sierra Ballroom A-B Speaker 5 of 5 Stacey S. Gallegos, University of California, Los Angeles, USA Short Talk: Glial-Enriched Progenitor Cells: A Novel Cell-Based Therapy for White Matter Stroke
Wednesday, March 28 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Cascades No registration fees are used to fund alcohol served at this function.
Wednesday, March 28 \| 7:30PM - 10:00PM Poster Session 3 Room: Alpine Ballroom
Thursday, March 29 \| 7:00AM - 8:00AM Breakfast Room: Cascades
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 1 of 7 * Joseph C. Wu, Stanford University School of Medicine, USA
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 2 of 7 Lorenz Studer, Memorial Sloan Kettering Cancer Center, USA Clinical Applications of Pluripotent Stem Cells
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 3 of 7 Misao Fujita, Kyoto University, Japan The Ethical, Social and Legal Aspects of iPSC Applications
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Coffee Break
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 5 of 7 Keiko Muguruma, RIKEN, Japan Construction of Brain Tissues from iPSCs for Investigation of Disease Mechanisms
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 6 of 7 Dominik Eckardt, Miltenyi Biotec GmbH, Germany Short Talk: Fully Integrated, Closed System for Expansion and Differentiation of Pluripotent Stem Cells toward Clinically Relevant Cell Populations and Scales
Thursday, March 29 \| 8:00AM - 11:00AM Clinical Applications of Stem Cells Room: Grand Sierra Ballroom A-B Speaker 7 of 7 Katja Gabriele Weinacht, Stanford School of Medicine, USA Short Talk: Human iPSC-Derived Thymic Epithelial Progenitor Cells as Stem Cell-Based Therapy to Restore Thymic Function in Hematopoietic Stem Cell Transplant Recipients
Thursday, March 29 \| 11:00AM - 5:00PM On Own for Lunch
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 1 of 9 * Yadong Huang, Gladstone Institutes/UCSF, USA
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 2 of 9 Osvaldo Antonio Miranda, California State University, Northridge, USA Derivation and Characterization of Rett iPSC Cerebral Organoids
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 3 of 9 Wei Niu, University of Michigan, USA Modeling Protocadherin-19 Female Limited Epilepsy in iPSC-Derived Neurons and Cerebral Organoids
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 4 of 9 Guoqiang Sun, City of Hope, USA Studying Microcephaly Induced by Human Cytomegalovirus (hCMV) in a Human iPSC-Derived 3D Biosystem
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 5 of 9 Li Li, City of Hope, USA Modeling Alexander Disease using Patient iPSC-Derived Astrocytes
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 6 of 9 Zhexing Wen, Emory University, USA Modeling Zika Virus Exposure and Screening Therapeutic Compounds with Human iPSC-Derived Neural Cells
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 7 of 9 Beate Winner, Friedrich-Alexander University Erlangen-Nürnberg, Germany Th17 Lymphocyte-Induced Neuronal Cell Death in Parkinson's Disease using an Autologous Human Stem Cell Based Model
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 8 of 9 Katharina Meyer, Harvard Medical School, USA Neural Progenitor Cell Function in Alzheimer's Disease
Thursday, March 29 \| 2:30PM - 4:30PM Workshop 3 Room: Grand Sierra Ballroom A-B Speaker 9 of 9 William T. Hendriks, Massachusetts General Hospital, USA Human iPSC-Based Disease Modeling Reveals a Retrotransposon with Repeat Expansion as the Causal Mechanism of X-Linked Dystonia Parkinsonism
Thursday, March 29 \| 4:30PM - 5:00PM Coffee Available Room: Sierra Prefunction
Thursday, March 29 \| 5:00PM - 6:45PM Manufacturing and Commercialization Room: Grand Sierra Ballroom A-B Speaker 1 of 4 * Lorenz Studer, Memorial Sloan Kettering Cancer Center, USA
Thursday, March 29 \| 5:00PM - 6:45PM Manufacturing and Commercialization Room: Grand Sierra Ballroom A-B Speaker 2 of 4 Eugenia M. Jones, Cellular Dynamics iNC, USA Human iPSC Creation and Biobanking
Thursday, March 29 \| 5:00PM - 6:45PM Manufacturing and Commercialization Room: Grand Sierra Ballroom A-B Speaker 3 of 4 Joseph C. Wu, Stanford University School of Medicine, USA Cardiac iPSCs for Precision Medicine and Clinical Trial in a Dish
Thursday, March 29 \| 5:00PM - 6:45PM Manufacturing and Commercialization Room: Grand Sierra Ballroom A-B Speaker 4 of 4 Mahendra S. Rao, New York Stem Cell Foundation, USA Consideration and Concerns in Manufacturing iPSC -Derived Products
Thursday, March 29 \| 6:45PM - 7:00PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) Room: Grand Sierra Ballroom A-B
Thursday, March 29 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Alpine Ballroom No registration fees are used to fund alcohol served at this function.
Thursday, March 29 \| 8:00PM - 11:00PM Entertainment Room: Alpine Ballroom Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
Thursday, March 29 \| 8:00PM - 11:00PM Cash Bar Room: Alpine Ballroom
Friday, March 30 \| 10:24AM - 10:24AM Departure *Session Chair †Invited, not yet responded.